p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes

References

• Beck S, Wojdyla D, Say L, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88:31–38.
   PubMed Web of Science ®Google Scholar
• Romero R, Yeo L, Miranda J, et al. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med. 2013;41:27–44.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Preterm birth: causes, consequences, and prevention. Washington (DC): National Academies Press; 2007.
   Google Scholar
• Mercer BM, Lewis R. Preterm labor and preterm premature rupture of the membranes. Diagnosis and management. Infect Dis Clin North Am. 1997;11:177–201.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84.
   PubMed Web of Science ®Google Scholar
• Menon R. Spontaneous preterm birth, a clinical dilemma: etiologic, pathophysiologic and genetic heterogeneities and racial disparity. Acta Obstet Gynecol Scand. 2008;87:590–600.
   PubMed Web of Science ®Google Scholar
• McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol. 2008;35:777–792.
   PubMed Web of Science ®Google Scholar
• Mallard C, Davidson JO, Tan S, et al. Astrocytes and microglia in acute cerebral injury underlying cerebral palsy associated with preterm birth. Pediatr Res. 2013;75:234–240.
   PubMed Web of Science ®Google Scholar
• Bersani I, Thomas W, Speer CP. Chorioamnionitis–the good or the evil for neonatal outcome? J Matern Fetal Neonatal Med. 2012;25 Suppl 1:12–16.
   PubMed Web of Science ®Google Scholar
• Wood NS, Marlow N, Costeloe K, et al. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med. 2000;343:378–384.
   PubMed Web of Science ®Google Scholar
• Källén B, Finnström O, Nygren K-G, et al. Association between preterm birth and intrauterine growth retardation and child asthma. Eur Respir J. 2013;41:671–676.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–2172.
   PubMed Web of Science ®Google Scholar
• Blencowe H, Lee AC, Cousens S, et al. Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010. Pediatr Res. 2013;74 Suppl 1:17–34.
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Gonçalves LF, et al. The role of inflammation and infection in preterm birth. Semin Reprod Med. 2007;25:21–39.
   PubMed Web of Science ®Google Scholar
• Gotsch F, Romero R, Kusanovic JP, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol. 2007;50:652–683.
   PubMed Web of Science ®Google Scholar
• Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122:369–382.
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Kusanovic JP, et al. The preterm parturition syndrome. BJOG. 2006;113 Suppl 3:17–42. BJO1120.
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998;179:194–202.
   PubMed Web of Science ®Google Scholar
• Kacerovsky M, Lenco J, Musilova I, et al. Proteomic biomarkers for spontaneous preterm birth: a systematic review of the literature. Reprod Sci. 2013;21:283–295.
   PubMed Web of Science ®Google Scholar
• Menon R, Swan KF, Lyden TW, et al. Expression of inflammatory cytokines (IL-1B, IL-6) in amniochorion. Am J Obstet Gynecol. 1995;172:493–500.
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato SJ. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig. 2004;11:427–437.
   PubMedGoogle Scholar
• Menon R, Fortunato SJ. Fetal membrane inflammatory cytokines: a switching mechanism between the preterm premature rupture of the membranes and preterm labor pathways. J Perinat Med. 2004;32:391–399.
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato SJ. Infection and the role of inflammation in preterm premature rupture of the membranes. Best Pract Res Clin Obstet Gynaecol. 2007;21:467–478.
   PubMed Web of Science ®Google Scholar
• Menon R, Peltier MR, Eckardt J, et al. Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes. Am J Obstet Gynecol. 2009;201:306.e1–306.e6.
   PubMed Web of Science ®Google Scholar
• Peltier MR, Richey LJ, Brown MB. Placental lesions caused by experimental infection of Sprague-Dawley rats with Mycoplasma pulmonis. Am J Reprod Immunol. 2003;50:254–262.
   PubMed Web of Science ®Google Scholar
• Peltier MR, Barney BM, Brown MB. Effect of experimental genital mycoplasmosis on production of matrix metalloproteinases in membranes and amniotic fluid of Sprague-Dawley rats. Am J Reprod Immunol. 2007;57:116–121.
   PubMed Web of Science ®Google Scholar
• Peltier MR, Drobek CO, Bhat G, et al. Amniotic fluid and maternal race influence responsiveness of fetal membranes to bacteria. J Reprod Immunol. 2012;96:68–78.
   PubMed Web of Science ®Google Scholar
• Velez DR, Fortunato SJ, Morgan N, et al. Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod. 2008;23:1902–1909.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Gravett MG, Iams J, et al. The preterm birth syndrome: issues to consider in creating a classification system. Am J Obstet Gynecol. 2012;206:113–118.
   PubMed Web of Science ®Google Scholar
• Behnia F, Peltier M, Getahun D, et al. High bisphenol A (BPA) concentration in the maternal, but not fetal, compartment increases the risk of spontaneous preterm delivery. J Matern Fetal Neonatal Med. 2016 Feb 24;1–7. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Ferguson KK, McElrath TF, Cantonwine DE, et al. Phthalate metabolites and bisphenol-A in association with circulating angiogenic biomarkers across pregnancy. Placenta. 2015;36:699–703.
   PubMed Web of Science ®Google Scholar
• O’Neill MS, Osornio-Vargas A, Buxton MA, et al. Air pollution, inflammation and preterm birth in Mexico City: study design and methods. Sci Total Environ. 2013;448:79–83.
   PubMed Web of Science ®Google Scholar
• Peltier MR, Koo H, Getahun D, et al. Does exposure to flame retardants increase the risk for preterm birth? J Reprod Immunol. 2014;107:20–25. S0165-0378(14)00157-0.
   PubMed Web of Science ®Google Scholar
• Rosen T, Kuczynski E, O’Neill LM, et al. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med. 2001;10:297–300.
   PubMedGoogle Scholar
• Romero R, Miranda J, Chaemsaithong P, et al. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2014;28:1–16.
   Google Scholar
• Romero R, Miranda J, Chaiworapongsa T, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 2014;72:458–474.
   PubMed Web of Science ®Google Scholar
• Behnia F, Sheller S, Menon R. Mechanistic differences leading to infectious and sterile inflammation. Am J Reprod Immunol. 2016;75:505–518.
   PubMed Web of Science ®Google Scholar
• Lockwood CJ. Recent advances in elucidating the pathogenesis of preterm delivery, the detection of patients at risk, and preventative therapies. Curr Opin Obstet Gynecol. 1994;6:7–18.
   PubMed Web of Science ®Google Scholar
• Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345:760–765.
   PubMed Web of Science ®Google Scholar
• Villar J, Gülmezoglu AM, de OM. Nutritional and antimicrobial interventions to prevent preterm birth: an overview of randomized controlled trials. Obstet Gynecol Surv. 1998;53:575–585.
   PubMedGoogle Scholar
• Harvey NC, Holroyd C, Ntani G, et al. Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess. 2014;18:1–190.
   Web of Science ®Google Scholar
• Berghella V, Baxter JK, Hendrix NW. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev. 2013;1:CD007235.
   PubMed Web of Science ®Google Scholar
• King J, Flenady V, Cole S, et al. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev. 2005;2:CD001992.
   Google Scholar
• Flenady V, Wojcieszek AM, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;6:CD002255.
   PubMed Web of Science ®Google Scholar
• Hackney DN, Olson-Chen C, Thornburg LL. What do we know about the natural outcomes of preterm labour? A systematic review and meta-analysis of women without tocolysis in preterm labour. Paediatr Perinat Epidemiol. 2013;27:452–460. doi:10.1111/ppe.12070.
   PubMed Web of Science ®Google Scholar
• Vogel JP, Nardin JM, Dowswell T, et al. Combination of tocolytic agents for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;7:CD006169.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R. Transdermal nitroglycerin for the treatment of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol. 2013;209:551.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R, Nicolaides K, et al. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol. 2013;208:42.e1–42.e18.
   Web of Science ®Google Scholar
• Saccone G, Saccone I, Berghella V. Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence? J Matern Fetal Neonatal Med. 2015;29:1–9.
   Web of Science ®Google Scholar
• Shennan AH, Chandiramani M. Antibiotics for spontaneous preterm birth. BMJ. 2008;337:a3015.
   PubMed Web of Science ®Google Scholar
• Webb DA, Mathew L, Culhane JF. Lessons learned from the Philadelphia Collaborative Preterm Prevention Project: the prevalence of risk factors and program participation rates among women in the intervention group. BMC Pregnancy Childbirth. 2014;14:368.
   PubMed Web of Science ®Google Scholar
• Thangaratinam S, Rogozińska E, Jolly K, et al. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technol Assess. 2012;16:1–191.
   Web of Science ®Google Scholar
• Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995;273:413–418.
   PubMed Web of Science ®Google Scholar
• Newnham JP, Jobe AH. Should we be prescribing repeated courses of antenatal corticosteroids? Semin Fetal Neonatal Med. 2009;14:157–163.
   PubMed Web of Science ®Google Scholar
• Lindström TM, Mohan AR, Johnson MR, et al. Histone deacetylase inhibitors exert time-dependent effects on nuclear factor-kappaB but consistently suppress the expression of proinflammatory genes in human myometrial cells. Mol Pharmacol. 2008;74:109–121.
   PubMed Web of Science ®Google Scholar
• Lappas M, Yee K, Permezel M, et al. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology. 2005;146:1491–1497.
   PubMed Web of Science ®Google Scholar
• De SD, Mitchell MD, Keelan JA. Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I-kappaB kinase (IKK) inhibitors. Br J Pharmacol. 2010;160:1808–1822.
   PubMed Web of Science ®Google Scholar
• Filipovich Y, Lu SJ, Akira S, et al. The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice. Am J Obstet Gynecol. 2009;200:93–98.
   PubMed Web of Science ®Google Scholar
• McCarthy FP, Delany AC, Kenny LC, et al. PPAR-gamma – a possible drug target for complicated pregnancies. Br J Pharmacol. 2013;168:1074–1085.
   PubMed Web of Science ®Google Scholar
• Lappas M, Permezel M, Rice GE. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab. 2003;88:1723–1729.
   PubMed Web of Science ®Google Scholar
• Buhimschi IA, Buhimschi CS, Weiner CP. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol. 2003;188:203–208.
   PubMed Web of Science ®Google Scholar
• Ng PY, Ireland DJ, Keelan JA. Drugs to block cytokine signaling for the prevention and treatment of inflammation-induced preterm birth. Front Immunol. 2015;6:166.
   PubMed Web of Science ®Google Scholar
• Newnham JP, Dickinson JE, Hart RJ, et al. Strategies to prevent preterm birth. Front Immunol. 2014;5:584.
   PubMed Web of Science ®Google Scholar
• Lim R, Lappas M. A novel role for GSK3 in the regulation of the processes of human labour. Reproduction. 2015;149:189–202.
   PubMed Web of Science ®Google Scholar
• Pirianov G, Waddington SN, Lindström TM, et al. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. Endocrinology. 2009;150:699–706.
   PubMed Web of Science ®Google Scholar
• Agrawal V, Smart K, Jilling T, et al. Surfactant protein (SP)-A suppresses preterm delivery and inflammation via TLR2. PLoS One. 2013;8:e63990.
   PubMed Web of Science ®Google Scholar
• Devi YS, DeVine M, DeKuiper J, et al. Inhibition of IL-6 signaling pathway by curcumin in uterine decidual cells. PLoS One. 2015;10:e0125627.
   PubMed Web of Science ®Google Scholar
• Nadeau-Vallée M, Quiniou C, Palacios J, et al. Novel noncompetitive IL-1 receptor-biased ligand prevents infection- and inflammation-induced preterm birth. J Immunol. 2015;195:3402–3415.
   PubMed Web of Science ®Google Scholar
• Fortunato SJ, Menon R, Swan KF, et al. Interleukin-10 inhibition of interleukin-6 in human amniochorionic membrane: transcriptional regulation. Am J Obstet Gynecol. 1996;175:1057–1065.
   PubMed Web of Science ®Google Scholar
• Fortunato SJ, Menon R, Lombardi SJ. Interleukin-10 and transforming growth factor-beta inhibit amniochorion tumor necrosis factor-alpha production by contrasting mechanisms of action: therapeutic implications in prematurity. Am J Obstet Gynecol. 1997;177:803–809.
   PubMed Web of Science ®Google Scholar
• Fortunato SJ, Menon R, Lombardi SJ. The effect of transforming growth factor and interleukin-10 on interleukin-8 release by human amniochorion may regulate histologic chorioamnionitis. Am J Obstet Gynecol. 1998;179:794–799.
   PubMed Web of Science ®Google Scholar
• Menon R. Oxidative stress damage as a detrimental factor in preterm birth pathology. Front Immunol. 2014;5:567.
   PubMed Web of Science ®Google Scholar
• Peter ST, Scholl TO, Schluter MD, et al. Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res. 2008;42:841–848.
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato SJ, Yu J, et al. Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta. 2011;32:317–322.
   PubMed Web of Science ®Google Scholar
• Menon R, Fortunato SJ, Milne GL, et al. Amniotic fluid eicosanoids in preterm and term births: effects of risk factors for spontaneous preterm labor. Obstet Gynecol. 2011;118:121–134.
   PubMed Web of Science ®Google Scholar
• Menon R, Yu J, Basanta-Henry P, et al. Short fetal leukocyte telomere length and preterm prelabor rupture of the membranes. PLoS One. 2012;7:e31136.
   PubMed Web of Science ®Google Scholar
• Dhobale M, Joshi S. Altered maternal micronutrients (folic acid, vitamin B(12)) and omega 3 fatty acids through oxidative stress may reduce neurotrophic factors in preterm pregnancy. J Matern Fetal Neonatal Med. 2012;25:317–323.
   PubMed Web of Science ®Google Scholar
• Chai M, Barker G, Menon R, et al. Increased oxidative stress in human fetal membranes overlying the cervix from term non-labouring and post labour deliveries. Placenta. 2012;33:604–610.
   PubMed Web of Science ®Google Scholar
• Menon R, Torloni MR, Voltolini C, et al. Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reprod Sci. 2011;18:1046–1070.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362:1282–1291.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R, Kusanovic JP, et al. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2011;204:503–512.
   PubMed Web of Science ®Google Scholar
• Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv. 2010;65:653–667.
   PubMed Web of Science ®Google Scholar
• Behnia F, Peltier MR, Saade GR, et al. Environmental pollutant polybrominated diphenyl ether, a flame retardant, induces primary amnion cell senescence. Am J Reprod Immunol. 2015;74:398–406.
   PubMed Web of Science ®Google Scholar
• Bredeson S, Papaconstantinou J, Deford JH, et al. HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes. PLoS One. 2014;9:e113799.
   PubMed Web of Science ®Google Scholar
• Polettini J, Behnia F, Taylor BD, et al. Telomere fragment induced amnion cell senescence: a contributor to parturition? PLoS One. 2015;10:e0137188.
   PubMed Web of Science ®Google Scholar
• Menon R, Boldogh I, Urrabaz-Garza R, et al. Senescence of primary amniotic cells via oxidative DNA damage. PLoS One. 2013;8:e83416.
   PubMed Web of Science ®Google Scholar
• Ruiz-Bonilla V, Perdiguero E, Gresh L, et al. Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases. Cell Cycle. 2008;7:2208–2214.
   PubMed Web of Science ®Google Scholar
• Perdiguero E, Ruiz-Bonilla V, Gresh L, et al. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J. 2007;26:1245–1256.
   PubMed Web of Science ®Google Scholar
• Risco A, del FC, Mambol A, et al. p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation. Proc Natl Acad Sci U S A. 2012;109:11200–11205.
   PubMed Web of Science ®Google Scholar
• Wang X, McGowan CH, Zhao M, et al. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol. 2000;20:4543–4552.
   PubMed Web of Science ®Google Scholar
• Kwong J, Chen M, Lv D, et al. Induction of p38δ expression plays an essential role in oncogenic ras-induced senescence. Mol Cell Biol. 2013;33:3780–3794.
   PubMed Web of Science ®Google Scholar
• Takeda K, Hatai T, Hamazaki TS, et al. Apoptosis signal-regulating kinase 1 (ASK1) induces neuronal differentiation and survival of PC12 cells. J Biol Chem. 2000;275:9805–9813.
   PubMed Web of Science ®Google Scholar
• Hsieh C-C, Kuro-o M, Rosenblatt KP, et al. The ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. Aging (Albany NY). 2010;2:597–611.
   PubMedGoogle Scholar
• Hsieh C-C, Papaconstantinou J. Dermal fibroblasts from long-lived Ames dwarf mice maintain their in vivo resistance to mitochondrial generated reactive oxygen species (ROS). Aging (Albany NY). 2009;1:784–802.
   PubMedGoogle Scholar
• Saitoh M, Nishitoh H, Fujii M, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998;17:2596–2606.
   PubMed Web of Science ®Google Scholar
• Papaconstantinou J, Hsieh C-C. Activation of senescence and aging characteristics by mitochondrially generated ROS: how are they linked? Cell Cycle. 2010;9:3831–3833.
   PubMed Web of Science ®Google Scholar
• Menon R, Behnia F, Polettini J, et al. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging (Albany NY). 2016;8:216–230.
   PubMedGoogle Scholar
• Dutta EH, Behnia F, Boldogh I, et al. Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes. Mol Hum Reprod. 2016;22:143–157.
   PubMed Web of Science ®Google Scholar
• Iwasa H, Han J, Ishikawa F. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells. 2003;8:131–144.
   PubMed Web of Science ®Google Scholar
• Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299–1307.
   PubMed Web of Science ®Google Scholar
• Polettini J, Dutta EH, Behnia F, et al. Aging of intrauterine tissues in spontaneous preterm birth and preterm premature rupture of the membranes: A systematic review of the literature. Placenta. 2015;36:969–973.
   PubMed Web of Science ®Google Scholar
• Yeung YT, Bryce NS, Adams S, et al. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J Neurooncol. 2012;109:35–44.
   PubMed Web of Science ®Google Scholar
• Guo X, Ma N, Wang J, et al. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer. 2008;8:375.
   PubMed Web of Science ®Google Scholar
• Graziosi L, Mencarelli A, Santorelli C, et al. Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. Eur J Pharmacol. 2012;674:143–152.
   PubMed Web of Science ®Google Scholar
• Bendotti C, Bao CM, Cheroni C, et al. Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase. Neurodegener Dis. 2005;2:128–134.
   PubMed Web of Science ®Google Scholar
• Kompa AR, See F, Lewis DA, et al. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction. J Pharmacol Exp Ther. 2008;325:741–750.
   PubMed Web of Science ®Google Scholar
• Liu C, Lin J, Wrobleski ST, et al. Discovery of 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases. J Med Chem. 2010;53:6629–6639.
   PubMed Web of Science ®Google Scholar
• Ferrari F, Facchinetti F, Saade G, et al. Placental telomere shortening in stillbirth: a sign of premature senescence? J Matern Fetal Neonatal Med. 2015;29:1–6.
   Web of Science ®Google Scholar
• Coulthard LR, White DE, Jones DL, et al. p38(MAPK): stress responses from molecular mechanisms to therapeutics. Trends Mol Med. 2009;15:369–379.
   PubMed Web of Science ®Google Scholar
• Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy–from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005;1754:253–262.
   PubMed Web of Science ®Google Scholar
• Montalban AG, Boman E, Chang C-D, et al. KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. Eur J Pharmacol. 2010;632:93–102.
   PubMed Web of Science ®Google Scholar
• Kim EK, Choi E-J. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802:396–405.
   PubMed Web of Science ®Google Scholar
• Parasrampuria DA, de BP, Desai-Krieger D, et al. Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study. J Clin Pharmacol. 2003;43:406–413.
   PubMed Web of Science ®Google Scholar
• Hsieh C-C, Papaconstantinou J. The effect of aging on p38 signaling pathway activity in the mouse liver and in response to ROS generated by 3-nitropropionic acid. Mech Ageing Dev. 2002;123:1423–1435.
   PubMed Web of Science ®Google Scholar
• Mannam P, Zhang X, Shan P, et al. Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury. J Immunol. 2013;190:1264–1275.
   PubMed Web of Science ®Google Scholar
• Hope HR, Anderson GD, Burnette BL, et al. Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation. J Pharmacol Exp Ther. 2009;331:882–895.
   PubMed Web of Science ®Google Scholar
• Xing L, Shieh HS, Selness SR, et al. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804. Biochemistry. 2009;48:6402–6411.
   PubMed Web of Science ®Google Scholar
• Selness SR, Devraj RV, Devadas B, et al. Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase. Bioorg Med Chem Lett. 2011;21:4066–4071.
   PubMed Web of Science ®Google Scholar
• Hasumi K, Sato S, Saito T, et al. Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isox azole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug concept. Bioorg Med Chem. 2014;22:4162–4176.
   PubMed Web of Science ®Google Scholar
• Shirota K, Kaneko M, Sasaki M, et al. Analysis of the disposition of a novel p38 MAPK inhibitor, AKP-001, and its metabolites in rats with a simple physiologically based pharmacokinetic model. Drug Metab Dispos. 2015;43:217–226.
   PubMed Web of Science ®Google Scholar
• Biggadike K, Angell RM, Burgess CM, et al. Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism. J Med Chem. 2000;43:19–21.
   PubMed Web of Science ®Google Scholar
• Freyne EJ, Lacrampe JF, Deroose F, et al. Synthesis and biological evaluation of 1,2,4-triazinylphenylalkylthiazolecarboxylic acid esters as cytokine-inhibiting antedrugs with strong bronchodilating effects in an animal model of asthma. J Med Chem. 2005;48:2167–2175.
   PubMed Web of Science ®Google Scholar
• Khan MO, Park KK, Lee HJ. Antedrugs: an approach to safer drugs. Curr Med Chem. 2005;12:2227–2239.
   PubMed Web of Science ®Google Scholar
• Shroot B, Caron JC, Ponec M. Glucocorticoid specific binding: structure-activity relationships. Br J Dermatol. 1982;107 Suppl 23:30–34.
   PubMed Web of Science ®Google Scholar
• Khan MO, Lee HJ. Synthesis and pharmacology of anti-inflammatory steroidal antedrugs. Chem Rev. 2008;108:5131–5145.
   PubMed Web of Science ®Google Scholar
• Roy SM, Grum-Tokars VL, Schavocky JP, et al. Targeting human central nervous system protein kinases: an isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer’s disease mouse models. ACS Chem Neurosci. 2015;6:666–680.
   PubMed Web of Science ®Google Scholar
• Satoh T, Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Annu Rev Pharmacol Toxicol. 1998;38:257–288.
   PubMed Web of Science ®Google Scholar
• Imai T. Human carboxylesterase isozymes: catalytic properties and rational drug design. Drug Metab Pharmacokinet. 2006;21:173–185.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Cooperwood JS, You Z, et al. Prodrug and antedrug: two diametrical approaches in designing safer drugs. Arch Pharm Res. 2002;25:111–136.
   PubMed Web of Science ®Google Scholar
• O’Donnell S, O’Morain CA. Therapeutic benefits of budesonide in gastroenterology. Ther Adv Chronic Dis. 2010;1:177–186. doi:10.1177/2040622310379293.
   PubMedGoogle Scholar
• Schreiber S, Feagan B, D’Haens G, et al. Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn’s disease: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006;4:325–334.
   PubMed Web of Science ®Google Scholar
• Sears MR. Descriptive epidemiology of asthma. Lancet. 1997;350 Suppl 2:SII1–SII4.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Therapeutic strategies for allergic diseases. Nature. 1999;402:B31–B38.
   PubMed Web of Science ®Google Scholar
• Wong ES, Le GX, Demidov ON, et al. p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age. Dev Cell. 2009;17:142–149.
   PubMed Web of Science ®Google Scholar
• Collins CJ, Sedivy JM. Involvement of the INK4a/Arf gene locus in senescence. Aging Cell. 2003;2:145–150.
   PubMed Web of Science ®Google Scholar
• Papaconstantinou J, Wang CZ, Zhang M, et al. Attenuation of p38α MAPK stress response signaling delays the in vivo aging of skeletal muscle myofibers and progenitor cells. Aging (Albany NY). 2015;7:718–733.
   PubMedGoogle Scholar
• Hsieh C-C, Papaconstantinou J. Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. FASEB J. 2006;20:259–268.
   PubMed Web of Science ®Google Scholar
• Menon R, Boldogh I, Hawkins HK, et al. Histological evidence of oxidative stress and premature senescence in preterm premature rupture of the human fetal membranes recapitulated in vitro. Am J Pathol. 2014;184:1740–1751.
   PubMed Web of Science ®Google Scholar
• Brobey RK, German D, Sonsalla PK, et al. Klotho protects dopaminergic neuron oxidant-induced degeneration by modulating ASK1 and p38 MAPK signaling pathways. PLoS One. 2015;10:e0139914.
   Web of Science ®Google Scholar